The S&P 500 gained 2.4% and the Nasdaq Composite 4.3% between selection dates (September 10, 2026 – October 8, 2026), while ...

Key TakeawaysAppLovin stock fell 12. 6% in the month through October 19, as advertising-growth concerns, litigation, and ...

Anthropic's IPO could be one of the biggest events for the stock market this year.

Mar Vista U.S. Quality strategy gained 1.45% in Q3 2026, driven by big tech. Read the full analysis for more details.

Broad Arrow Auctions, driven by Hagerty (NYSE: HGTY), is excited to follow its record-setting Zoute Concours Auction with a return to the spectacular Dolder Grand for its second Zürich Auction, the ...

On Tuesday, Actinium Pharmaceuticals Inc. ATNM announced encouraging initial clinical results from its first-in-human Phase 1 study of ATNM-400 for metastatic castration-resistant prostate cancer ...

Third quarter revenue of $1,143 million increased 3% sequentiallyThird quarter operating income of $153 million increased 43% sequentiallyThird ...

People are right to want control over their homes and their futures. Socialized housing, not private ownership, can make that promise a reality for everyone.

Disc Medicine announces pricing of $450 million upsized public offering of common stock, funding research and development for ...

The Facebook founder tagged John Ternus on his rival’s social platform as Meta released an AI model built to run on Apple’s ...

In the ALK-rearranged NCI-H3122 model, ATNM-400 plus crizotinib achieved 97% TGI, compared with 50% for ATNM-400, 55% for crizotinib and 26% for patritumab deruxtecan alone. ATNM-400-containing ...

HUTCHMED announces closing of agreement with GSK for HMPL-A830, a targeted therapy for KRAS-altered cancers.